Leveraging the Tracking Operations and Outcomes for Plastic Surgeons Database for Plastic Surgery Research: A "How-To" Guide.


Journal

Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050

Informations de publication

Date de publication:
01 Nov 2021
Historique:
pubmed: 17 9 2021
medline: 19 1 2022
entrez: 16 9 2021
Statut: ppublish

Résumé

The Plastic Surgeries Registry Network supported by the American Society of Plastic Surgeons (ASPS) and the Plastic Surgery Foundation offers a variety of options for procedural data and outcomes assessment and research. The Tracking Operations and Outcomes for Plastic Surgeons (TOPS) database is a registry created for and used by active members of ASPS to monitor all types of procedural outcomes. It functions as a way for individual or group practices to follow surgical outcomes and constitutes a huge research registry available to ASPS members to access for registry-based projects. The TOPS registry was launched in 2002 and has undergone several iterations and improvements over the years and now includes more than 1 million procedure records. Although ASPS member surgeons have proven valuable assets in contributing their data to the TOPS registry, fewer have leveraged the database for registry-based research. This article overviews the authors' experience using the TOPS registry for a database research project to demonstrate the process, usefulness, and accessibility of TOPS data for ASPS member surgeons to conduct registry-based research. This article pairs with the report of the authors' TOPS registry investigation related to 30-day adverse events associated with incision location for augmentation mammaplasty.

Identifiants

pubmed: 34529595
doi: 10.1097/PRS.0000000000008483
pii: 00006534-202111000-00015
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

735e-741e

Informations de copyright

Copyright © 2021 by the American Society of Plastic Surgeons.

Déclaration de conflit d'intérêts

Disclosure:The authors have no commercial associations or financial disclosures that might pose or create a conflict of interest with information presented in this article.

Références

Bottle A, Cohen C, Lucas A, et al. How an electronic health record became a real-world research resource: Comparison between London’s Whole Systems Integrated Care database and the Clinical Practice Research Datalink. BMC Med Inform Decis Mak. 2020;20:71.
Colquhoun DA, Shanks AM, Kapeles SR, et al. Considerations for integration of perioperative electronic health records across institutions for research and quality improvement: The approach taken by the Multicenter Perioperative Outcomes Group. Anesth Analg. 2020;130:1133–1146.
Shi W, Kelsey T, Sullivan F. Efficient identification of patients eligible for clinical studies using case-based reasoning on Scottish Health Research register (SHARE). BMC Med Inform Decis Mak. 2020;20:70.
Wang L, Chang-rui WU. Database model and applications for electronic medical records (EMRs) system. DEStech Transact Comput Sci Eng. 2019;1:85–88.
Lunet N. Epidemiology: Current Perspectives on Research and Practice. 2012.London: IntechOpen Limited;
Hu Z, Melton GB, Arsoniadis EG, Wang Y, Kwaan MR, Simon GJ. Strategies for handling missing clinical data for automated surgical site infection detection from the electronic health record. J Biomed Inform. 2017;68:112–120.
Papageorgiou G, Grant SW, Takkenberg JJM, Mokhles MM. Statistical primer: How to deal with missing data in scientific research? Interact Cardiovasc Thorac Surg. 2018;27:153–158.
Madhu G, Bharadwaj BL, Nagachandrika G, Vardhan KS. A novel algorithm for missing data imputation on machine learning. Paper presented at: 2019 International Conference on Smart Systems Inventive Technology (ICSSIT); November 27–29, 2019; Tirunelveli, India.
Vieira BL, Lanier ST, Mlodinow AS, et al. A multi-institutional analysis of insurance status as a predictor of morbidity following breast reconstruction. Plast Reconstr Surg Glob Open2014;2:e255.
Khavanin N, Jordan SW, Vieira BL, et al. Combining abdominal and cosmetic breast surgery does not increase short-term complication rates: A comparison of each individual procedure and pretreatment risk stratification tool. Aesthet Surg J. 2015;35:999–1006.
Kim JY, Mlodinow AS, Khavanin N, et al. Individualized risk of surgical complications: An application of the breast reconstruction risk assessment score. Plast Reconstr Surg Glob Open2015;3:e405.
Chow I, Alghoul MS, Khavanin N, et al. Is there a safe lipoaspirate volume? A risk assessment model of liposuction volume as a function of body mass index. Plast Reconstr Surg. 2015;136:474–483.
Drury KE, Lanier ST, Khavanin N, et al. Impact of postoperative antibiotic prophylaxis duration on surgical site infections in autologous breast reconstruction. Ann Plast Surg. 2016;76:174–179.
Vieira BL, Chow I, Sinno S, Dorfman RG, Hanwright P, Gutowski KA. Is there a limit? A risk assessment model of liposuction and lipoaspirate volume on complications in abdominoplasty. Plast Reconstr Surg. 2018;141:892–901.
Pannucci CJ, Antony AK, Wilkins EG. The impact of acellular dermal matrix on tissue expander/implant loss in breast reconstruction: An analysis of the tracking outcomes and operations in plastic surgery database. Plast Reconstr Surg. 2013;132:1–10.
Alderman AK, Collins ED, Streu R, et al. Benchmarking outcomes in plastic surgery: National complication rates for abdominoplasty and breast augmentation. Plast Reconstr Surg. 2009;124:2127–2133.
Manahan MA, Wooden WA, Becker SM, et al. Evidence-based performance measures: Quality metrics for the care of patients undergoing breast reconstruction. Plast Reconstr Surg. 2017;140:775e–781e.

Auteurs

Denis Souto Valente (DS)

From the Mãe de Deus Health System; University of Missouri-Kansas City School of Medicine; University of Kansas School of Medicine; Department of Research, American Society of Plastic Surgeons; Graduate Program in Medicine and Health Sciences, Pontifical University Catholic Rio Grande do Sul; Division of Plastic Surgery, Division of Health Services Research, University of Utah; and Plastic Surgery Northwest.

Alison E Kaye (AE)

From the Mãe de Deus Health System; University of Missouri-Kansas City School of Medicine; University of Kansas School of Medicine; Department of Research, American Society of Plastic Surgeons; Graduate Program in Medicine and Health Sciences, Pontifical University Catholic Rio Grande do Sul; Division of Plastic Surgery, Division of Health Services Research, University of Utah; and Plastic Surgery Northwest.

Christopher J Simmons (CJ)

From the Mãe de Deus Health System; University of Missouri-Kansas City School of Medicine; University of Kansas School of Medicine; Department of Research, American Society of Plastic Surgeons; Graduate Program in Medicine and Health Sciences, Pontifical University Catholic Rio Grande do Sul; Division of Plastic Surgery, Division of Health Services Research, University of Utah; and Plastic Surgery Northwest.

Rafaela K Zanella (RK)

From the Mãe de Deus Health System; University of Missouri-Kansas City School of Medicine; University of Kansas School of Medicine; Department of Research, American Society of Plastic Surgeons; Graduate Program in Medicine and Health Sciences, Pontifical University Catholic Rio Grande do Sul; Division of Plastic Surgery, Division of Health Services Research, University of Utah; and Plastic Surgery Northwest.

Christopher J Pannucci (CJ)

From the Mãe de Deus Health System; University of Missouri-Kansas City School of Medicine; University of Kansas School of Medicine; Department of Research, American Society of Plastic Surgeons; Graduate Program in Medicine and Health Sciences, Pontifical University Catholic Rio Grande do Sul; Division of Plastic Surgery, Division of Health Services Research, University of Utah; and Plastic Surgery Northwest.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH